^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

IL10 underexpression

i
Other names: IL10, CSIF, IL-10, IL10A, TGIF, Interleukin 10
Entrez ID:
Related biomarkers:
Associations
Trials
1year
Study of the proviral load levels and mRNA expression of cytokines in peripheral blood mononuclear cells and somatic milk cells in cattle with different BLV infection profiles. (PubMed, Vet Ital)
This study shows that milk SC maintains lower proviral load levels than PBMC. This first report on Th1 and Th2 cytokines expression levels in SC may be relevant to future control strategies for BLV infection, mastitis, and udder health management.
Journal
|
IFNG (Interferon, gamma) • IL6 (Interleukin 6) • IL10 (Interleukin 10)
|
IFNG expression • IL6 expression • IL10 underexpression
almost3years
Interleukin-10 receptor signaling promotes the maintenance of a PD-1 TCF-1 CD8 T cell population that sustains anti-tumor immunity. (PubMed, Immunity)
Low IL10 expression or loss of IL-10R-STAT3 signaling correlated with increased frequencies of exhausted CD8 T cells and poor survival in CLL and in breast cancer patients. Thus, balance between PD-1, exhausted CD8 T cells and functional PD-1 TCF-1 CD8 T cells is regulated by cell-intrinsic IL-10R signaling, with implications for immunotherapy.
Clinical • Journal • PD(L)-1 Biomarker • IO biomarker
|
CD8 (cluster of differentiation 8) • PD-1 (Programmed cell death 1) • IL10 (Interleukin 10)
|
IL10 underexpression
4years
Tumor Response to Irinotecan is Associated with IL-10 Expression Level in Metastatic Colorectal Cancer-Results from mCRC Biomarker Study. (PubMed, Onco Targets Ther)
All the enrolled patients received an oxaliplatin-containing or irinotecan-containing regimen. In addition, the low IL-10 expression level in tumor tissue was significantly associated with the improved OS for the irinotecan-containing regimen (p = 0.023). Our study demonstrated that IL-10 could act as a prognostic biomarker for mCRC patients undergoing irinotecan-containing chemotherapy.
Journal
|
IL10 (Interleukin 10)
|
IL10 underexpression
|
oxaliplatin • irinotecan
over4years
[VIRTUAL] Tumor response to irinotecan is associated with IL-10 expression level in metastatic colorectal cancer - Results from mCRC biomarker study (ESMO 2020)
All the enrolled patients received oxaliplatin-containing or irinotecan-containing regimen. Funding: Has not received any funding. Clinical trial identification: NCT03532711 (retrospectively registered: May 20th, 2018).
IL10 (Interleukin 10)
|
IL10 underexpression
|
oxaliplatin • irinotecan